BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Adenosine Therapeutics, LLC (Acquired by Parexel International) 

Press releases archived for reference only.
P.O. Box 4632
Charlottesville  Virginia  22905  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






 Company News
Adenosine Therapeutics Engages Needham & Company to Explore Strategic Options for Phase III Cardiac Stress Agent 4/1/2013 10:50:55 AM    More...
Clinical Data Acquires Adenosine Therapeutics 8/5/2008 6:45:53 AM    More...
Adenosine Therapeutics Announces Election of Dr. Jonathan Sackier as Company Chairman and Dr. H. Jeffrey Leighton as Vice Chairman 11/13/2007 10:36:24 AM    More...
Adenosine Therapeutics Announces Appointment of Drs. Jonathan Sackier and Steven Tregay to the Board of Directors 6/25/2007 11:28:20 AM    More...
Adenosine Therapeutics Awarded Phase II SBIR Grant To Treat Asthma And STTR Grant To Develop New Treatment For Sepsis 10/26/2006 10:36:47 AM    More...
Adenosine Therapeutics Initiates Phase Ib Clinical Study With ATL146e 10/25/2006 10:50:33 AM    More...
Adenosine Therapeutics Awarded SBIR Grant To Develop New Compounds For The Treatment Of Parkinson's Disease 10/19/2005 5:12:46 PM    More...
Adenosine Therapeutics Announces $3.5 Million In Funding 10/19/2005 5:12:32 PM    More...
Adenosine Therapeutics Announces Collaboration With Ortho-McNeil Pharmaceutical, Inc. To Develop Novel Oral Drugs For Diabetes And Asthma 10/19/2005 5:12:24 PM    More...
National Institutes of Health (NIH) Awards Adenosine Therapeutics Phase II SBIR Grant To Develop New Drug Eluting Stent To Prevent Restenosis 10/19/2005 5:12:22 PM    More...
12

//-->